BNC Share Price

Open 21.40 Change Price %
High 21.40 1 Day 0.00 0.00
Low 21.40 1 Week 0.00 0.00
Close 21.40 1 Month 1.25 6.20
Volume 7 1 Year 21.19 10090.48
52 Week High 21.57
52 Week Low 20.15
BNC Important Levels
Resistance 2 21.40
Resistance 1 21.40
Pivot 21.40
Support 1 21.40
Support 2 21.40
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BTO 3.38 1.81%
BTO 3.38 1.81%
SC 60.83 -0.44%
PRE 0.64 0.00%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
DA-A 0.23 35.29%
ANX 0.06 20.00%
ANX 0.06 20.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
CXA-B 1.10 11.11%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
PWC 0.10 -16.67%
PWC 0.10 -16.67%
TOS 2.25 -11.42%
TOS 2.25 -11.42%
BX 0.85 -10.53%
BX 0.85 -10.53%
CET 0.48 -9.43%
CET 0.48 -9.43%
DNT 0.10 -9.09%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 28th Nov 2016 BNC Share Price closed @ 21.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.87 & Strong Buy for SHORT-TERM with Stoploss of 2.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for December
1st Target up-side 22.17
2nd Target up-side 22.72
3rd Target up-side 23.26
1st Target down-side 20.63
2nd Target down-side 20.08
3rd Target down-side 19.54
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.